Stan C Kieskamp
Overview
Explore the profile of Stan C Kieskamp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kieskamp S, van der Kraan Y, Arends S, Wink F, Bos R, Stewart R, et al.
Rheumatology (Oxford)
. 2025 Feb;
PMID: 39985440
Objectives: In a substantial portion of patients with axial spondyloarthritis (axSpA), disease activity scores remain high despite anti-inflammatory treatment. This is possibly due to factors beyond active inflammation including different...
2.
Ausma N, van der Kraan Y, de Wolff L, Kokol H, Carbo M, Kieskamp S, et al.
Clin Exp Rheumatol
. 2024 Dec;
42(12):2468-2475.
PMID: 39656594
Objectives: Regular physical activity is recommended in patients with rheumatic diseases. In order to uniformly measure physical activity, our aim was to perform field testing of the modified Short QUestionnaire...
3.
van der Kraan Y, Gensler L, Paap D, Thovmasyan E, Ausma N, Kokol H, et al.
RMD Open
. 2024 Oct;
10(4).
PMID: 39448204
Background: The modified Short QUestionnaire to ASsess Health-enhancing physical activity (mSQUASH) was originally developed and validated in Dutch patients with axial spondyloarthritis (axSpA). To support world-wide distribution, applicability and comparability...
4.
Siderius M, Kieskamp S, Wink F, Kroese F, Arends S, Spoorenberg A
Biologics
. 2023 Dec;
17:161-166.
PMID: 38115870
Background: Our objective was to explore bone-related outcome and bone turnover markers (BTM) during 2 years of secukinumab treatment in patients with radiographic axial spondyloarthritis (r-axSpA) in daily clinical practice....
5.
van der Kraan Y, Paap D, Lennips N, Veenstra E, Wink F, Kieskamp S, et al.
Rheumatol Ther
. 2023 Jul;
10(5):1349-1368.
PMID: 37523038
Introduction: Within the EULAR recommendations, patient education (PE) is stated as the basis of the management of axial spondyloarthritis (axSpA). However, educational needs are scarcely qualitatively studied in axSpA. Therefore,...
6.
Kieskamp S, Paap D, Carbo M, Wink F, Bos R, Bootsma H, et al.
Semin Arthritis Rheum
. 2022 Jan;
52:151933.
PMID: 35033996
Introduction: Persistent pain has large potential impact on quality of life (QoL). During the course of the disease, many patients with axial spondyloarthritis (axSpA) report persistent pain. Central sensitization (CS)...
7.
Kieskamp S, Paap D, Carbo M, Wink F, Bos R, Bootsma H, et al.
Rheumatology (Oxford)
. 2021 Jan;
60(10):4476-4485.
PMID: 33492397
Objectives: Many patients with axial spondyloarthritis (axSpA) report persistent pain even when treated with anti-inflammatory agents. Our aim was to explore the presence of central sensitization (CS) and different types...